Asymptomatic prostatitis: inflammation without complaints, what to do

Asymptomatic inflammatory prostatitis is a finding, not a "disease with complaints": a man experiences no pain or urinary disturbances, but histological examinations or tests reveal signs of prostate inflammation. It is most often discovered incidentally—with elevated prostate-specific antigen levels, during fertility assessments, or in biopsies taken for other reasons. The treatment approach here is fundamentally different than for symptomatic forms: "do no harm" is more important than "treat anything." [1]

Current guidelines recommend not confusing category IV with chronic pelvic pain syndrome and bacterial forms: these conditions have different evaluation goals and different indications for treatment. For category IV, observation and correction of associated factors are usually sufficient, and empirical antibiotics "just in case" in the absence of infection are a bad idea. [2]

It's also important to understand the "biology of the finding": lymphocytes and macrophages are often visible in the prostate under microscopy; such infiltrates can increase prostate-specific antigen (PSA) and are found in benign prostatic hyperplasia (BPH). This explains why some men experience PSA fluctuations without cancer. However, this doesn't mean everyone should be treated with antibiotics. [3]

Finally, the doctor’s goal here is not to “eradicate inflammation at any cost,” but to rule out something dangerous (for example, prostate cancer according to indications), not to prescribe unnecessary things, and to give a clear plan for when and what to retake in order to reduce anxiety. [4]

Where it fits in: modern classification

Table 1. NIH classification of prostatitis and category IV ranking

Type	How to briefly describe	Are there any symptoms?	What is most important
I. Acute bacterial	Sudden infectious inflammation	Yes	Urgent antibiotics, rule out abscess
II. Chronic bacterial	Recurrent infections with one strain	Yes	Prove localization and treat the cause of relapses
IIIA/IIIB. Chronic prostatitis/chronic pelvic pain syndrome	Long-term pelvic pain with/without inflammatory cells	Yes	Multimodal pain and function control
IV. Asymptomatic inflammatory prostatitis	Inflammation according to analysis/histology	No	Eliminate the important, do not overtreat, observe
Source: EAU, Prostatitis Section and CPPS (2024 update). [5]

How it is coded: ICD-10 and ICD-11

There is no separate code for "asymptomatic inflammatory prostatitis" in ICD-10. In practice, N41.1 ("chronic prostatitis") or N41.9 ("inflammatory disease of the prostate, unspecified") are used – the choice depends on local regulations and context (why we code: statistics, counting, reporting). [6]

ICD-11 uses the GA91 block "Inflammatory and other diseases of the prostate." There is no specific code for "asymptomatic inflammatory prostatitis"; GA91.0 ("chronic prostatitis") or GA91.Y ("other specified inflammatory or other diseases of the prostate") are more commonly used, with clinical clarification in the diagnosis. [7]

Table 2. Codes for reporting

Classification	The closest code in meaning	How to write in a diagnosis
ICD-10	N41.1 / N41.9	Asymptomatic inflammatory prostatitis (NIH category IV)
ICD-11	GA91.0 / GA91.Y	The same + indicate that it was detected laboratory/histologically
Based on the current versions of ICD-10-CM and ICD-11 MMS. [8]

How common is this?

Prevalence varies greatly depending on the site of investigation. In population-based surveys of asymptomatic men, the proportion of men with NIH-IV status based on semen analysis (leukocytospermia) ranges from approximately 6% in young men to 21% in adult samples. This is not a "disease," but a laboratory phenomenon. [9]

In prostate histology (biopsies for elevated prostate-specific antigen or surgical specimens), signs of chronic inflammation are frequently found—40% or more, depending on criteria and age. This explains why inflammatory findings are the norm rather than the exception in older men. [10]

Inflammatory changes and calcifications are more common in patients with benign prostatic hyperplasia (BPH) than in those without it; the association with the severity of lower urinary tract symptoms varies across studies. These are associations, not proven causation. [11]

Table 3. Where and with what frequency are category IV cases “caught”?

Context	What do they find?	Estimated frequency
Sperm screening in young people	Leukocytospermia ≥ 1,000,000/ml without complaints	≈ 6%
Population 19-78 years old	Leukocytospermia/category IV	≈ 21%
Biopsies for elevated prostate-specific antigen	Chronic inflammation in the columns	≈ 40% and above
Data from different cohorts and methods; variability is expected. [12]

Why does it arise?

Histologically, chronic inflammation with lymphocytes and macrophages in the stroma and around the ducts is evident. Ejaculate contains elevated leukocytes, and interleukin-6, a marker of local inflammation, is often elevated. This reflects an immune response, not necessarily an active infection. [13]

Category IV often goes hand in hand with benign prostatic hyperplasia and age-related changes. At the tissue level, chronic inflammation can be accompanied by stromal remodeling and collagen formation, which in some men is associated with symptoms of obstruction, but in the absence of complaints, treatment is not necessary "just in case." [14]

Leukocytospermia is a laboratory criterion, not a diagnosis. The World Health Organization considers a white blood cell count of over 1,000,000 per milliliter of ejaculate (with peroxidase verification) to be significant. This threshold triggers further evaluation, but does not automatically prescribe antibiotics. [15]

The ejaculate microbiota is richer in species in some men, but the association of these findings with clinical benefit from antibiotics in the absence of symptoms remains weak. [16]

How is this revealed in practice?

There are three reasons: 1) elevated prostate-specific antigen without complaints; 2) leukocytes in the semen during a fertility assessment; 3) inflammatory changes in a biopsy taken for another reason. The diagnosis is descriptive, not clinical: “inflammation without symptoms was detected.” [17]

When prostate-specific antigen is elevated, the key step is to repeat the prostate-specific antigen test at the prescribed interval, rather than administering a "trial" antibiotic. The American Urological Association clearly emphasizes that empirical antibiotics should not be used to "treat" an isolated elevated prostate-specific antigen in an asymptomatic patient. [18]

In andrological practice, when leukocytospermia is present, it is recommended to confirm leukocyte counts with a peroxidase test and, if indicated, perform a culture (if treatment is planned to improve fertility). The World Health Organization threshold is more than 1,000,000 leukocytes per milliliter. [19]

Table 4. Minimum reasonable diagnostics

Situation	What to do	For what
Elevated prostate-specific antigen, no complaints	Repeat prostate-specific antigen in the coming months; evaluate factors for false elevation	Avoid unnecessary antibiotics and biopsies
Leukocytes in sperm	Peroxidase test; if planning pregnancy, culture as indicated	Separate true leukocytes from precursor cells
Inflammation in biopsy	Provide a clinical explanation, but without "autotherapy"	This is a discovery, not a reason for a course of antibiotics.
Based on AUA and World Health Organization.[20]

What it is not: differential diagnosis

Category IV – non-chronic bacterial prostatitis: there are recurrent infections with a single strain and response to antibacterial therapy. There are no symptoms and no locally proven infection. [21]

This is also not a chronic pelvic pain syndrome: pain dominates for 3 months or longer, and localization cultures are usually negative; pain and functional impairment are treated, not a “latent infection.” [22]

With elevated prostate-specific antigen, it is important to distinguish inflammation from prostate cancer. A repeat prostate-specific antigen (PSA) test, free prostate-specific antigen (FPSA) percentage, risk calculators, and magnetic resonance imaging (MRI) are helpful when indicated, but not an "antibiotic challenge," which does not improve the accuracy of biopsy selection. [23]

Table 5. What is confused with what and how to separate

Looks like	What is "for"?	What's "against"
Chronic bacterial prostatitis	Recurrent urinary tract infections with one strain	There are no complaints in category IV and the localization is not confirmed.
Chronic pelvic pain syndrome	Long-term pain, dysfunction	In category IV there is no pain or functional complaints
Prostate cancer	Persistent elevation of prostate-specific antigen, MR signs	Antibiotic challenge does not improve biopsy selection accuracy
The key is not to treat blindly, but to choose the next step correctly. [24]

Treat or observe: what the current data say

The basic rule is simple: if there are no symptoms and no proven infection, there is no treatment. Observation, repeated prostate-specific antigen measurements according to guidelines, and management of associated risk factors are necessary. This is the position of guidelines on chronic pelvic pain and early detection of prostate cancer. [25]

Empirical antibiotics prescribed solely for elevated prostate-specific antigen (PSA) are not recommended: randomized and review data show that a decrease in PSA after a course of treatment does not differentiate inflammation from cancer and may only delay proper diagnosis. The exception is clinical signs of infection, in which case treatment is standard. [26]

In andrology, a targeted approach to leukocytospermia in infertile couples is possible: confirming leukocyte counts, searching for and treating a specific infection if confirmed, and discussing anti-inflammatory and supportive treatments. However, "antibiotics for everyone with leukocyte counts" is not a strategy: the effect on fertility is inconclusive. [27]

Table 6. When to treat and when to observe

Scenario	What to do	Comment
Only elevated prostate-specific antigen, no complaints	Repeat prostate-specific antigen; assess factors and risks	Do not give antibiotics "to lower prostate-specific antigen"
Leukocytes in semen of a couple with infertility	Confirm by test; culture as indicated; targeted therapy if infection is detected	The goal is fertility benefits, not “normalization of numbers.”
Histological inflammation without complaints	Explain the finding; observe	Therapy is not indicated
Based on AUA (early detection of prostate cancer), EAU and World Health Organization. [28]

A special question: prostate-specific antigen and "what to do with the number"

Almost any inflammatory episode in the prostate can temporarily elevate prostate-specific antigen levels. The correct approach is to repeat the test after a reasonable interval (often 6-8 weeks or more, depending on clinical preference), rather than "knock down" the level with antibiotics. This is precisely how recommendations for the early detection of prostate cancer are formulated. [29]

A decrease in prostate-specific antigen after a course of antibiotics does not prove the absence of cancer and does not improve the accuracy of subsequent diagnostic steps. It is better to use a repeat test, free prostate-specific antigen (FPA), risk calculators, and magnetic resonance imaging (MRI) as indicated. [30]

Table 7. Management of elevated prostate-specific antigen in an asymptomatic patient

Step	What exactly	For what
1	Repeat prostate-specific antigen	Eliminate transient increases
2	Estimate prostate-free antigen/risk calculators	Reduce excess biopsies
3	Discuss prostate magnetic resonance imaging (by risk)	Improve biopsy selection
4	Do not prescribe empirical antibiotics for the sake of "lowering prostate-specific antigen"	This does not improve the accuracy of diagnosis.
AUA/SUO Summary and Current Reviews. [31]

Prevention and "decision hygiene"

An informed diagnosis is the best prevention: repeat the prostate-specific antigen test, rather than "treat the number." Discuss factors that can cause a temporary increase (ejaculation the day before, intense cycling, acute infections) and adjust the timing of testing. [32]

In andrology, for leukocytospermia, use standardized approaches from the World Health Organization: peroxidase verification of leukocytes, repeat testing, and culture studies as indicated. This reduces overdiagnosis and unnecessary drug treatment. [33]

Reduce overall urologic risks: avoid unnecessary catheterization, promptly treat urogenital infections, manage metabolic health factors - this is beneficial regardless of category IV. [34]

Forecast

Category IV is a finding with a generally favorable prognosis. In most men, it requires no treatment and does not affect life expectancy. The main risks are not related to the cancer itself, but to overtreatment and delays in necessary cancer diagnostics due to the "antibiotic trial." [35]

There are associations between chronic inflammation of the prostate and the severity of hyperplasia symptoms, but a cause-and-effect relationship has not been proven; in the absence of complaints, there is no need to treat the “inflammation itself.” [36]

Frequently asked questions

Should asymptomatic inflammatory prostatitis be treated?
No. In the absence of complaints and without proven infection, treatment is not required. Monitoring and proper management of prostate-specific antigen are necessary. [37]

Should I give antibiotics if I simply have an elevated prostate-specific antigen?
No. It's recommended to repeat the prostate-specific antigen test and continue risk assessment, rather than "knock down" the level with antibiotics. Empirical antibiotics in asymptomatic patients are a mistake. [38]

Are leukocytes in semen a diagnosis?
It's a laboratory finding. The World Health Organization considers a leukocyte count of over 1,000,000 per milliliter, confirmed by peroxidase, to be significant. Further decisions are made based on the situation (pregnancy plans, identified infection). [39]

Could category IV explain a high prostate-specific antigen?
Yes, inflammation can temporarily elevate prostate-specific antigen. However, a decrease in prostate-specific antigen after antibiotics does not rule out cancer and should not be a criterion for biopsy. [40]

Is it true that "inflammation leads to hyperplasia" and should be treated proactively?
There are observational links between inflammation and the severity of symptoms of benign hyperplasia, but there's no need to treat asymptomatic inflammation proactively. Decisions are made based on clinical findings and risk. [41]

Brief patient information sheet

Table 8. What to do if you have “inflammation without complaints”

Situation	Act One	What not to do
Elevated prostate-specific antigen	Repeat prostate-specific antigen, discuss risk calculator and MRI as indicated	Don't ask for "an antibiotic for prostate-specific antigen"
Leukocytes in sperm	Confirm with a test; if planning a pregnancy, culture/treatment as indicated	Don't take long courses "just in case"
Inflammation in biopsy	Discuss it calmly with your doctor; more often, just observe.	Don't consider this as "the inevitable onset of illness"
Key point: less reflexes, more precision. [42]